Retatrutide Starts at $375* Retatrutide is an advanced triple-action metabolic therapy designed to support significant weight loss, optimize metabolic function, and enhance overall energy balance by targeting GLP-1, GIP, and glucagon pathways
The tirzepatide versus semaglutide dosage chart lays out the differences clearly
Over-the-counter options Simethicone (Gas-X, Mylanta Gas) works by breaking down gas bubbles in the digestive tract, making them easier to pass
The FDA cited language suggesting MEDVi was the compounder of these drugs and claims the agency stated implied FDA approval or evaluation of compounded products
Beyond Just Weight Loss Emerging research suggests GLP-1 receptor agonists may improve sleep apnea through mechanisms beyond pure weight reduction
Interrelationship of dipeptidyl peptidase IV (DPP4) with the development of diabetes, dyslipidaemia and nephropathy: a streptozotocin-induced model using wild-type and DPP4-deficient rats